Literature DB >> 17578765

The molecular pathogenesis of childhood adrenocortical tumors.

M Q Almeida1, A C Latronico.   

Abstract

Adrenocortical tumors in children and adolescents are rare events. However, the high incidence of adrenocortical tumors in children from the Southern region of Brazil is particularly remarkable, since it has been estimated to be approximately 10-15 times greater than the worldwide incidence. To date, there are no histological or molecular markers that can reliably distinguish benign from malignant adrenocortical tumors. The study of rare genetic syndromes associated with adrenocortical tumors has greatly contributed to the elucidation of sporadic adrenocortical tumorigenesis. Recently, considerable advances toward understanding the molecular mechanisms of adrenocortical tumorigenesis in Brazilian children and adolescents with sporadic adrenocortical tumors have been made. Some of the molecular aspects of sporadic adrenocortical tumors arising in children and adolescents are reviewed here.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17578765     DOI: 10.1055/s-2007-981476

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  6 in total

Review 1.  Review paper: origin and molecular pathology of adrenocortical neoplasms.

Authors:  M Bielinska; H Parviainen; S Kiiveri; M Heikinheimo; D B Wilson
Journal:  Vet Pathol       Date:  2009-03       Impact factor: 2.221

Review 2.  Neonatal Cushing Syndrome: A Rare but Potentially Devastating Disease.

Authors:  Christina Tatsi; Constantine A Stratakis
Journal:  Clin Perinatol       Date:  2017-12-12       Impact factor: 3.430

3.  Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions.

Authors:  S A Boikos; A Horvath; S Heyerdahl; E Stein; A Robinson-White; I Bossis; J Bertherat; J A Carney; C A Stratakis
Journal:  Horm Metab Res       Date:  2008-05       Impact factor: 2.936

4.  Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma.

Authors:  Gabriela Resende Vieira de Sousa; Tamaya C Ribeiro; Andre M Faria; Beatriz M P Mariani; Antonio M Lerario; Maria Claudia N Zerbini; Iberê C Soares; Alda Wakamatsu; Venancio A F Alves; Berenice B Mendonca; Maria Candida B V Fragoso; Ana Claudia Latronico; Madson Q Almeida
Journal:  Oncotarget       Date:  2015-09-08

Review 5.  Mouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking?

Authors:  Felicia Leccia; Marie Batisse-Lignier; Isabelle Sahut-Barnola; Pierre Val; A-Marie Lefrançois-Martinez; Antoine Martinez
Journal:  Front Endocrinol (Lausanne)       Date:  2016-07-15       Impact factor: 5.555

Review 6.  Apoptosis regulation in adrenocortical carcinoma.

Authors:  Sofia S Pereira; Mariana P Monteiro; Sonir R Antonini; Duarte Pignatelli
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.